In The News,
Novel International Molecular Diagnostic System
For a novel molecular diagnostic system in the US and seven EU countries, gained internal alignment on pricing to determine current estimated costs, expert views of the novel system, value of savings associated with system adoption, acceptable costs, and impact of future changes in regulation and reimbursement.